DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Larkin J, Lao CD, Urba WJ. et al.
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.
JAMA Oncol 2015;
1: 433-440
We do not assume any responsibility for the contents of the web pages of other providers.